Last reviewed · How we verify
NCT05062512: HANDDS-ONT
Health in Aging, Neurodegenerative Diseases and Dementias In Ontario
trial in Neuro-Degenerative Disease in 250 participants. Terminated before completion.
31 March 2023
Quick facts
| Lead sponsor | Ontario Neurodegeneration Disease Research Initiative |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 26 August 2021 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across Canada |
Conditions studied
- Neuro-Degenerative Disease — all drugs for Neuro-Degenerative Disease →
- Dementia — all drugs for Dementia →
Sponsor
Ontario Neurodegeneration Disease Research Initiative
Who can join
18 and older, any sex, with Neuro-Degenerative Disease or Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Health in Aging, Neurodegenerative Diseases and DementiaS in ONTario (HANDDS-ONT) Study is an observational study that takes place in the comfort of participant's home, with no study visits occurring in a clinic. The study is recruiting people living with a neurodegenerative disease or the effects of stroke, along with healthy, aging individuals. Studying both groups will help ONDRI researchers to: 1. understand how the diseases affect different people 2. discover ways to potentially detect diseases earlier 3. find ways to help people manage their daily health related behaviours Participant data is collected virtually through wearables - small sensors worn on the wrist, ankle and chest -- for 7-10 days, as participants go about their daily activities. Data is also collected from questionnaires regarding mood and quality of life. Blood samples will be collected to understand how one's genetic makeup could provide for earlier detection of some conditions, and for analysis of certain risk factors. Combining the information from the sensors (walking patterns, sleep, heart rate/rhythm, etc.), the questionnaires and the blood samples will allow researchers to better understand aging, with and without a neurodegenerative condition, over a period of time. Participants will receive a personalized health and activity report, describing sleep and activity during the time the wearable sensors were worn. This information may help participants better understand and manage some aspects of their overall health and it can be shared with their circle of care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05062512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neuro-Degenerative Disease
Currently open trials in the same condition.
- NCT07126821 — A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data · recruiting
- NCT06151600 — A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J · recruiting
- NCT05175417 — Visualization of Neural Targets With 3T MRI · recruiting
- NCT05655650 — Identifying Biomarkers in Alzheimer's Disease · recruiting
- NCT03233646 — Retinal Imaging in Neurodegenerative Disease · recruiting
Other Ontario Neurodegeneration Disease Research Initiative trials
Trials by the same sponsor.
- NCT04104373 — The Ontario Neurodegenerative Disease Research Initiative · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05062512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ontario Neurodegeneration Disease Research Initiative
- Last refreshed: 2 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05062512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing